Breaking News Instant updates and real-time market news.

NVCR

Novocure

$152.50 /

-20.85 (-12.03%)

13:30
02/25/21
02/25
13:30
02/25/21
13:30

'Overreaction to downside' in Novocure a buying opportunity, says Piper Sandler

Piper Sandler analyst Jason Bednar notes Novocure reported Q4 results, including revenue of $144M that capped off a strong year that consisted of nearly $500M in revenue and progress across the company's large and expanding clinical pipeline. There was a lot of attention paid to the trial milestone updates, and it's these adjustments that seem to be causing an "overreaction to the downside" in shares on Thursday, the analyst contended. However, Bednar argues that there's nothing he sees in Q4 results or heard on the conference call that alters his positive long-term fundamental view of Novocure's TTField technology and the potential it has to provide for significant long-term growth via indication and market expansion. Therefore, he would encourage long-term investors to use the move lower as an opportunity to get involved or increase exposure with Novocure ahead of a catalyst-rich next couple years. The analyst reiterates an Overweight rating and a $225 price target on the shares.

  • 25

    Feb

NVCR Novocure
$152.50 /

-20.85 (-12.03%)

01/29/21 Truist
Novocure price target raised to $132 from $118 at Truist
01/25/21 Piper Sandler
Novocure price target raised to $225 from $140 at Piper Sandler
01/12/21 Wedbush
Novocure price target raised to $159 from $110 at Wedbush
10/30/20 Mizuho
Novocure price target raised to $150 from $84 at Mizuho

TODAY'S FREE FLY STORIES

Hot Stocks
Vertex Pharmaceuticals appoints Yvette Burton as chief people innovation officer » 08:49
04/12/21
04/12
08:49
04/12/21
08:49
VRTX

Vertex Pharmaceuticals

$213.43 /

+3.01 (+1.43%)

Vertex is honored to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$213.43 /

+3.01 (+1.43%)

VRTX Vertex Pharmaceuticals
$213.43 /

+3.01 (+1.43%)

03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
02/23/21 Baird
Baird upgrades Vertex Pharmaceuticals, shares attractive ahead of readouts
02/23/21 Baird
Vertex Pharmaceuticals upgraded to Outperform from Neutral at Baird
02/02/21 Credit Suisse
Vertex Pharmaceuticals price target lowered to $280 from $285 at Credit Suisse
VRTX Vertex Pharmaceuticals
$213.43 /

+3.01 (+1.43%)

VRTX Vertex Pharmaceuticals
$213.43 /

+3.01 (+1.43%)

VRTX Vertex Pharmaceuticals
$213.43 /

+3.01 (+1.43%)

VRTX Vertex Pharmaceuticals
$213.43 /

+3.01 (+1.43%)

Hot Stocks
Sanofi to invest EUR 400M in vaccine production site in Singapore » 08:49
04/12/21
04/12
08:49
04/12/21
08:49
SNY

Sanofi

$50.80 /

+0.43 (+0.85%)

Sanofi announced a plan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$50.80 /

+0.43 (+0.85%)

SNY Sanofi
$50.80 /

+0.43 (+0.85%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SNY Sanofi
$50.80 /

+0.43 (+0.85%)

SNY Sanofi
$50.80 /

+0.43 (+0.85%)

SNY Sanofi
$50.80 /

+0.43 (+0.85%)

Conference/Events
GMS Inc. management to meet virtually with Truist » 08:49
04/12/21
04/12
08:49
04/12/21
08:49
GMS

GMS Inc.

$42.34 /

+0.63 (+1.51%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GMS GMS Inc.
$42.34 /

+0.63 (+1.51%)

GMS GMS Inc.
$42.34 /

+0.63 (+1.51%)

03/05/21 Truist
GMS price target raised to $42 from $34 at Truist
03/05/21 Barclays
GMS Inc. price target raised to $37 from $35 at Barclays
12/04/20
Fly Intel: Top five analyst downgrades
12/04/20 Stephens
Stephens downgrades GMS Inc. to Equal Weight, sees few near-term catalysts
GMS GMS Inc.
$42.34 /

+0.63 (+1.51%)

Hot Stocks
Riot Blockchain produces 187 bitcoin in March » 08:48
04/12/21
04/12
08:48
04/12/21
08:48
RIOT

Riot Blockchain

$49.64 /

+0.17 (+0.34%)

Riot Blockchain announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RIOT Riot Blockchain
$49.64 /

+0.17 (+0.34%)

RIOT Riot Blockchain
$49.64 /

+0.17 (+0.34%)

11/23/20 H.C. Wainwright
Riot Blockchain price target raised to $7.50 from $3.50 at H.C. Wainwright
RIOT Riot Blockchain
$49.64 /

+0.17 (+0.34%)

RIOT Riot Blockchain
$49.64 /

+0.17 (+0.34%)

RIOT Riot Blockchain
$49.64 /

+0.17 (+0.34%)

Downgrade
Vaalco Energy downgraded to Neutral from Buy at Roth Capital » 08:47
04/12/21
04/12
08:47
04/12/21
08:47
EGY

Vaalco Energy

$2.25 /

-0.015 (-0.66%)

Roth Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EGY Vaalco Energy
$2.25 /

-0.015 (-0.66%)

EGY Vaalco Energy
$2.25 /

-0.015 (-0.66%)

03/24/21 Roth Capital
Vaalco Energy initiated with a Buy at Roth Capital
Periodicals
General Motors' Cruise to expand self-driving vehicles to Dubai, CNBC reports » 08:46
04/12/21
04/12
08:46
04/12/21
08:46
GM

General Motors

$60.15 /

+0.08 (+0.13%)

General Motors'…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$60.15 /

+0.08 (+0.13%)

GM General Motors
$60.15 /

+0.08 (+0.13%)

04/05/21
Fly Intel: Top five analyst initiations
04/05/21 Wells Fargo
General Motors initiated with an Overweight at Wells Fargo
03/29/21 Jefferies
General Motors price target raised to $62 from $50 at Jefferies
03/24/21 Morgan Stanley
American Axle downgraded to Underweight on ICE phase out risk at Morgan Stanley
GM General Motors
$60.15 /

+0.08 (+0.13%)

GM General Motors
$60.15 /

+0.08 (+0.13%)

GM General Motors
$60.15 /

+0.08 (+0.13%)

GM General Motors
$60.15 /

+0.08 (+0.13%)

Recommendations
Qualtrics price target lowered to $38 from $45 at BMO Capital » 08:45
04/12/21
04/12
08:45
04/12/21
08:45
XM

Qualtrics

$32.09 /

-0.52 (-1.59%)

BMO Capital analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XM Qualtrics
$32.09 /

-0.52 (-1.59%)

XM Qualtrics
$32.09 /

-0.52 (-1.59%)

04/09/21 Barclays
Qualtrics price target lowered to $35 from $39 at Barclays
03/17/21
Fly Intel: Top five analyst initiations
03/17/21 HSBC
Qualtrics initiated with a Hold at HSBC
03/17/21 HSBC
Qualtrics initiated with a Hold at HSBC
XM Qualtrics
$32.09 /

-0.52 (-1.59%)

  • 28
    Jan
XM Qualtrics
$32.09 /

-0.52 (-1.59%)

XM Qualtrics
$32.09 /

-0.52 (-1.59%)

XM Qualtrics
$32.09 /

-0.52 (-1.59%)

Hot Stocks
Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail » 08:45
04/12/21
04/12
08:45
04/12/21
08:45
CP

Canadian Pacific

$375.60 /

+0.475 (+0.13%)

, KSU

Kansas City Southern

$262.21 /

-0.01 (-0.00%)

Canadian Pacific Railway…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

04/09/21 Scotiabank
Canadian Pacific price target raised to C$516 from C$510 at Scotiabank
04/06/21 Susquehanna
Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
03/31/21 National Bank
National Bank upgrades Canadian Pacific on likelihood of deal approval
03/30/21 National Bank
Canadian Pacific upgraded to Outperform from Sector Perform at National Bank
KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

04/06/21 Susquehanna
Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
03/31/21 National Bank
National Bank upgrades Canadian Pacific on likelihood of deal approval
03/26/21 Vertical Research
Kansas City Southern reinstated with a Hold at Vertical Research
03/23/21 Cowen
Wabtec remains positioned to benefit from rail market, says Cowen
CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

Hot Stocks
Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail » 08:45
04/12/21
04/12
08:45
04/12/21
08:45
CP

Canadian Pacific

$375.60 /

+0.475 (+0.13%)

, KSU

Kansas City Southern

$262.21 /

-0.01 (-0.00%)

Canadian Pacific Railway…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

04/09/21 Scotiabank
Canadian Pacific price target raised to C$516 from C$510 at Scotiabank
04/06/21 Susquehanna
Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
03/31/21 National Bank
National Bank upgrades Canadian Pacific on likelihood of deal approval
03/30/21 National Bank
Canadian Pacific upgraded to Outperform from Sector Perform at National Bank
KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

04/06/21 Susquehanna
Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
03/31/21 National Bank
National Bank upgrades Canadian Pacific on likelihood of deal approval
03/26/21 Vertical Research
Kansas City Southern reinstated with a Hold at Vertical Research
03/23/21 Cowen
Wabtec remains positioned to benefit from rail market, says Cowen
CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

Options
Largest borrow rate increases among liquid names » 08:45
04/12/21
04/12
08:45
04/12/21
08:45
SGLB

Sigma Labs

$3.75 /

-0.04 (-1.06%)

, CHPT

ChargePoint

$27.64 /

-0.93 (-3.26%)

, BLNK

Blink Charging

$44.04 /

-1.89 (-4.11%)

, AYRO

AYRO

$5.89 /

-0.01 (-0.17%)

, IGC

India Globalization Capital

$1.73 /

-0.005 (-0.29%)

, THCB

Tuscan Holdings Corp.

$12.61 /

+0.21 (+1.69%)

, TRIL

Trillium Therapeutics

$10.45 /

-0.73 (-6.53%)

, INVZ

Innoviz Technologies

$12.08 /

+0.25 (+2.11%)

, BLDP

Ballard Power

$23.29 /

-0.775 (-3.22%)

Latest data shows the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGLB Sigma Labs
$3.75 /

-0.04 (-1.06%)

CHPT ChargePoint
$27.64 /

-0.93 (-3.26%)

BLNK Blink Charging
$44.04 /

-1.89 (-4.11%)

AYRO AYRO
$5.89 /

-0.01 (-0.17%)

IGC India Globalization Capital
$1.73 /

-0.005 (-0.29%)

THCB Tuscan Holdings Corp.
$12.61 /

+0.21 (+1.69%)

TRIL Trillium Therapeutics
$10.45 /

-0.73 (-6.53%)

BLDP Ballard Power
$23.29 /

-0.775 (-3.22%)

SGLB Sigma Labs
$3.75 /

-0.04 (-1.06%)

CHPT ChargePoint
$27.64 /

-0.93 (-3.26%)

03/25/21 Citi
ChargePoint initiated with a Neutral at Citi
03/08/21 Cowen
ChargePoint initiated with an Outperform at Cowen
03/08/21 Cowen
ChargePoint initiated with an Outperform at Cowen
03/02/21 Oppenheimer
ChargePoint initiated with an Outperform at Oppenheimer
BLNK Blink Charging
$44.04 /

-1.89 (-4.11%)

03/08/21 Cowen
Blink Charging initiated with an Outperform at Cowen
02/05/21 Roth Capital
Blink Charging initiated with a Buy at Roth Capital
08/14/20
Fly Intel: Top five analyst downgrades
08/14/20 H.C. Wainwright
Blink Charging downgraded to Neutral from Buy at H.C. Wainwright
AYRO AYRO
$5.89 /

-0.01 (-0.17%)

IGC India Globalization Capital
$1.73 /

-0.005 (-0.29%)

03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
THCB Tuscan Holdings Corp.
$12.61 /

+0.21 (+1.69%)

TRIL Trillium Therapeutics
$10.45 /

-0.73 (-6.53%)

11/18/20 Craig-Hallum
Trillium Therapeutics price target raised to $21 from $15 at Craig-Hallum
11/04/20 Cowen
Trillium ASH abstracts provide 'minimal updates', says Cowen
10/12/20 Evercore ISI
Trillium Therapeutics initiated with an Outperform at Evercore ISI
10/05/20 Piper Sandler
Patent fight likely to weigh on ALX Oncology shares NT, says Piper Sandler
INVZ Innoviz Technologies
$12.08 /

+0.25 (+2.11%)

BLDP Ballard Power
$23.29 /

-0.775 (-3.22%)

03/30/21 Northcoast
Ballard Power initiated with a Neutral at Northcoast
03/12/21 Lake Street
Ballard Power price target raised to $35 from $20 at Lake Street
03/12/21 BMO Capital
Ballard Power price target lowered to $35 from $38 at BMO Capital
03/12/21 Citi
Ballard Power price target lowered to $33 from $42 at Citi
CHPT ChargePoint
$27.64 /

-0.93 (-3.26%)

BLNK Blink Charging
$44.04 /

-1.89 (-4.11%)

AYRO AYRO
$5.89 /

-0.01 (-0.17%)

TRIL Trillium Therapeutics
$10.45 /

-0.73 (-6.53%)

BLDP Ballard Power
$23.29 /

-0.775 (-3.22%)

  • 10
    Mar
  • 10
    Feb
  • 08
    Jan
  • 08
    Jan
  • 24
    Nov
  • 11
    Sep
BLNK Blink Charging
$44.04 /

-1.89 (-4.11%)

IGC India Globalization Capital
$1.73 /

-0.005 (-0.29%)

CHPT ChargePoint
$27.64 /

-0.93 (-3.26%)

BLNK Blink Charging
$44.04 /

-1.89 (-4.11%)

AYRO AYRO
$5.89 /

-0.01 (-0.17%)

IGC India Globalization Capital
$1.73 /

-0.005 (-0.29%)

THCB Tuscan Holdings Corp.
$12.61 /

+0.21 (+1.69%)

TRIL Trillium Therapeutics
$10.45 /

-0.73 (-6.53%)

SGLB Sigma Labs
$3.75 /

-0.04 (-1.06%)

CHPT ChargePoint
$27.64 /

-0.93 (-3.26%)

BLNK Blink Charging
$44.04 /

-1.89 (-4.11%)

AYRO AYRO
$5.89 /

-0.01 (-0.17%)

IGC India Globalization Capital
$1.73 /

-0.005 (-0.29%)

THCB Tuscan Holdings Corp.
$12.61 /

+0.21 (+1.69%)

TRIL Trillium Therapeutics
$10.45 /

-0.73 (-6.53%)

INVZ Innoviz Technologies
$12.08 /

+0.25 (+2.11%)

BLDP Ballard Power
$23.29 /

-0.775 (-3.22%)

Hot Stocks
Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail » 08:44
04/12/21
04/12
08:44
04/12/21
08:44
CP

Canadian Pacific

$375.60 /

+0.475 (+0.13%)

, KSU

Kansas City Southern

$262.21 /

-0.01 (-0.00%)

Canadian Pacific Railway…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

04/09/21 Scotiabank
Canadian Pacific price target raised to C$516 from C$510 at Scotiabank
04/06/21 Susquehanna
Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
03/31/21 National Bank
National Bank upgrades Canadian Pacific on likelihood of deal approval
03/30/21 National Bank
Canadian Pacific upgraded to Outperform from Sector Perform at National Bank
KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

04/06/21 Susquehanna
Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
03/31/21 National Bank
National Bank upgrades Canadian Pacific on likelihood of deal approval
03/26/21 Vertical Research
Kansas City Southern reinstated with a Hold at Vertical Research
03/23/21 Cowen
Wabtec remains positioned to benefit from rail market, says Cowen
CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

CP Canadian Pacific
$375.60 /

+0.475 (+0.13%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

KSU Kansas City Southern
$262.21 /

-0.01 (-0.00%)

Hot Stocks
Roche confirms REGN-COV 2069 trial met primary and key secondary endpoints » 08:43
04/12/21
04/12
08:43
04/12/21
08:43
RHHBY

Roche

$41.93 /

+0.53 (+1.28%)

, REGN

Regeneron

$475.52 /

-0.61 (-0.13%)

Roche (RHHBY) confirmed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$41.93 /

+0.53 (+1.28%)

REGN Regeneron
$475.52 /

-0.61 (-0.13%)

RHHBY Roche
$41.93 /

+0.53 (+1.28%)

08:33 Today B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
REGN Regeneron
$475.52 /

-0.61 (-0.13%)

03/24/21 Canaccord
Regeneron trial shows positive results against COVID-variants, says Canaccord
03/23/21 Piper Sandler
Regeneron lower dose cocktail likely to be added to EUA, says Piper Sandler
03/11/21 Evercore ISI
Kodiak Sciences initiated with an Outperform at Evercore ISI
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
RHHBY Roche
$41.93 /

+0.53 (+1.28%)

REGN Regeneron
$475.52 /

-0.61 (-0.13%)

  • 27
    May
RHHBY Roche
$41.93 /

+0.53 (+1.28%)

REGN Regeneron
$475.52 /

-0.61 (-0.13%)

RHHBY Roche
$41.93 /

+0.53 (+1.28%)

REGN Regeneron
$475.52 /

-0.61 (-0.13%)

REGN Regeneron
$475.52 /

-0.61 (-0.13%)

Hot Stocks
GTEC Holdings repays $6M loan, eliminates all debt » 08:41
04/12/21
04/12
08:41
04/12/21
08:41
GGTTF

GTEC Holdings

/

+

GTEC is pleased to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GGTTF GTEC Holdings
/

+

Hot Stocks
Popular raises dividend to 45c per share, announces $350M stock repurchase plan » 08:40
04/12/21
04/12
08:40
04/12/21
08:40
BPOP

Popular

$71.50 /

+0.27 (+0.38%)

Popular announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BPOP Popular
$71.50 /

+0.27 (+0.38%)

BPOP Popular
$71.50 /

+0.27 (+0.38%)

01/29/21 RBC Capital
Popular price target raised to $70 from $48 at RBC Capital
01/08/21 UBS
Popular upgraded to Buy from Neutral at UBS
09/22/20
Top five analyst initiations
09/22/20 UBS
Popular initiated with a Neutral at UBS
BPOP Popular
$71.50 /

+0.27 (+0.38%)

Hot Stocks
Lottery.com signs engagement letter with Ritzio International » 08:39
04/12/21
04/12
08:39
04/12/21
08:39
TDAC

Trident Acquisitions Corp.

$13.27 /

+0.345 (+2.67%)

Lottery.com has signed an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TDAC Trident Acquisitions Corp.
$13.27 /

+0.345 (+2.67%)

Earnings
CACI Names Glenn Kurowski CTO » 08:39
04/12/21
04/12
08:39
04/12/21
08:39
CACI

CACI

$251.61 /

+2.4 (+0.96%)

CACI International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CACI CACI
$251.61 /

+2.4 (+0.96%)

CACI CACI
$251.61 /

+2.4 (+0.96%)

03/26/21 Stifel
Stifel downgrades SAIC to Hold after 'materially reset' expectations
02/23/21 William Blair
William Blair reiterates Outperform on Leidos following quarterly results
01/29/21 Truist
CACI price target raised to $290 from $275 at Truist
01/27/21 Stifel
CACI 'very likely' to bid on Perspecta as well, says Stifel
CACI CACI
$251.61 /

+2.4 (+0.96%)

Hot Stocks
Allogene, Springworks announce first patient dosed in Phase 1 study of ALLO-715 » 08:38
04/12/21
04/12
08:38
04/12/21
08:38
ALLO

Allogene Therapeutics

$32.83 /

-0.83 (-2.47%)

, SWTX

SpringsWorks Therapeutics

$69.00 /

-2.23 (-3.13%)

Allogene Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$32.83 /

-0.83 (-2.47%)

SWTX SpringsWorks Therapeutics
$69.00 /

-2.23 (-3.13%)

ALLO Allogene Therapeutics
$32.83 /

-0.83 (-2.47%)

03/01/21 H.C. Wainwright
Allogene Therapeutics price target raised to $43 from $40 at H.C. Wainwright
01/26/21 Stifel
Allogene Therapeutics upgraded to Buy from Hold at Stifel
12/28/20 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $87 from $73 at H.C. Wainwright
12/10/20 H.C. Wainwright
Allogene Therapeutics assumed with a Buy at H.C. Wainwright
SWTX SpringsWorks Therapeutics
$69.00 /

-2.23 (-3.13%)

03/30/21 JPMorgan
SpringsWorks Therapeutics added to Analyst Focus List at JPMorgan
02/26/21 Barclays
SpringsWorks Therapeutics price target raised to $105 from $92 at Barclays
02/25/21 H.C. Wainwright
SpringsWorks price target raised to $124 from $101 at H.C. Wainwright
01/22/21 Barclays
SpringsWorks Therapeutics price target raised to $92 from $83 at Barclays
ALLO Allogene Therapeutics
$32.83 /

-0.83 (-2.47%)

SWTX SpringsWorks Therapeutics
$69.00 /

-2.23 (-3.13%)

  • 02
    Mar
  • 08
    Oct
  • 02
    Jun
ALLO Allogene Therapeutics
$32.83 /

-0.83 (-2.47%)

SWTX SpringsWorks Therapeutics
$69.00 /

-2.23 (-3.13%)

General news
Fed Chair Powell reiterated the FOMC will continue to support the recovery » 08:38
04/12/21
04/12
08:38
04/12/21
08:38
$ECON

Economic Data

/

+

Fed Chair Powell…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    Downgrade
    Argo Group downgraded to Neutral from Outperform at Boenning & Scattergood » 08:38
    04/12/21
    04/12
    08:38
    04/12/21
    08:38
    ARGO

    Argo Group

    $54.05 /

    -0.13 (-0.24%)

    Boenning &…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ARGO Argo Group
    $54.05 /

    -0.13 (-0.24%)

    ARGO Argo Group
    $54.05 /

    -0.13 (-0.24%)

    03/15/21 HSBC
    Argo Group price target raised to $10.25 from $7 at HSBC
    03/15/21 Compass Point
    Argo Group upgraded to Buy from Neutral at Compass Point
    01/06/21 Compass Point
    Argo Group price target raised to $47 from $41 at Compass Point
    11/11/20 Compass Point
    Argo Group downgraded to Neutral after vaccine-fueled rally at Compass Point
    ARGO Argo Group
    $54.05 /

    -0.13 (-0.24%)

    Hot Stocks
    Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    GNPX

    Genprex

    $4.46 /

    -0.415 (-8.51%)

    Genprex announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    01/26/21 National Securities
    Genprex initiated with a Buy at National Securities
    04/22/20 Alliance Global Partners
    Genprex initiated with a Buy at Alliance Global Partners
    Hot Stocks
    Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    GNPX

    Genprex

    $4.46 /

    -0.415 (-8.51%)

    Genprex announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    01/26/21 National Securities
    Genprex initiated with a Buy at National Securities
    04/22/20 Alliance Global Partners
    Genprex initiated with a Buy at Alliance Global Partners
    Hot Stocks
    Talend: 'Go-shop' period expires related to Thoma Bravo acquistion » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    TLND

    Talend

    $64.71 /

    +0.27 (+0.42%)

    Talend announced the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    TLND Talend
    $64.71 /

    +0.27 (+0.42%)

    TLND Talend
    $64.71 /

    +0.27 (+0.42%)

    03/11/21
    Fly Intel: Top five analyst downgrades
    03/11/21 Needham
    Talend downgraded to Hold from Buy at Needham
    03/10/21 Craig-Hallum
    Talend go-shop 'could spark interest,' says Craig-Hallum
    03/10/21 William Blair
    Talend downgraded to Market Perform from Outperform at William Blair
    TLND Talend
    $64.71 /

    +0.27 (+0.42%)

    TLND Talend
    $64.71 /

    +0.27 (+0.42%)

    Hot Stocks
    Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    GNPX

    Genprex

    $4.46 /

    -0.415 (-8.51%)

    Genprex announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    01/26/21 National Securities
    Genprex initiated with a Buy at National Securities
    04/22/20 Alliance Global Partners
    Genprex initiated with a Buy at Alliance Global Partners
    Hot Stocks
    Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    GNPX

    Genprex

    $4.46 /

    -0.415 (-8.51%)

    Genprex announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    01/26/21 National Securities
    Genprex initiated with a Buy at National Securities
    04/22/20 Alliance Global Partners
    Genprex initiated with a Buy at Alliance Global Partners
    Recommendations
    Alibaba named a Research Tactical Idea at Morgan Stanley » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    BABA

    Alibaba

    $223.35 /

    -4.9 (-2.15%)

    Morgan Stanley analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    07:37 Today Raymond James
    Alibaba price target lowered to $330 from $350 at Raymond James
    06:41 Today Mizuho
    Alibaba antitrust ruling 'removes overhang,' says Mizuho
    06:37 Today Citi
    Alibaba fine could help lift 'overhang' on shares, says Citi
    06:36 Today KeyBanc
    Alibaba price target lowered to $305 from $315 at KeyBanc
    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.